1253
URC 2025. MPU and Roche have entered into an investment agreement to localize the manufacturing of medicines in Ukraine
Medical Procurement of Ukraine and the international pharmaceutical company Roche have entered into an investment agreement to localize the manufacturing of oncology medicines in Ukraine.
593
Tax benefits for transfer of medicinal products expanded: Law adopted
On July 3, 2025, Law of Ukraine No. 4472-IX came into force, expanding patient access to medicinal products. The law introduces new opportunities for the procurement of medicinal products under managed entry agreements.
622
Pharmaceutical Forum "FARMEXPERT 2025: eCTD and pricing in Ukraine"
Lidiia Sanzharovska and Viktoriya Hanzhelo participated in the pharmaceutical forum "Pharmexpert 2025. eCTD and Pricing in Ukraine – a Strategic Path to Integration into the International Regulatory Space".
1282
LA Law Firm wins UAH 151 million tax dispute at pretrial stage
The client is a major enterprise that imports and exports products from Ukraine. The tax authority denied the VAT refund because the VAT amount arose not from a tax credit, but from the adjustment of overstated VAT liabilities.
1050
Pharmaceutical market in 2025: what are the first effects of the new price regulation?
A webinar on 'Revolutionary changes in the regulation of the pharmaceutical market of Ukraine: UPDATE' was recently held, organised by LA Law Firm, with the Apteka.UA Weekly as the media partner.
